生物技术通报 ›› 2025, Vol. 41 ›› Issue (10): 334-342.doi: 10.13560/j.cnki.biotech.bull.1985.2025-0199

• 研究报告 • 上一篇    下一篇

虾青素对黄曲霉毒素B1诱导肝损伤的缓解作用及机制

杨微1,2(), 关海峰3, 任欣慧4, 彭金菊1, 陈志宝1()   

  1. 1.广东海洋大学滨海农业学院,湛江 524088
    2.华南农业大学兽医学院,广州 510642
    3.江苏三仪生物工程有限公司,邳州 221000
    4.苏州赛赋新药技术服务有限责任公司,苏州 215021
  • 收稿日期:2025-02-25 出版日期:2025-10-26 发布日期:2025-10-28
  • 通讯作者: 陈志宝,男,博士,教授,研究方向 :兽医药理与毒理学;E-mail: chenzb@gdou.edu.cn
  • 作者简介:杨微,女,博士研究生,研究方向 :兽医药理与毒理学;E-mail: 15776581772@163.com
  • 基金资助:
    广东省普通高校重点领域专项(乡村振兴)(2020ZDZX1043);广东海洋大学科研启动经费资助项目(R20061)

Alleviating Effect of Astaxanthin on Liver Injury Induced by Aflatoxin B 1 and Its Mechanism

YANG Wei1,2(), GUAN Hai-feng3, REN Xin-hui4, PENG Jin-ju1, CHEN Zhi-bao1()   

  1. 1.College of Coastal Agricultural Sciences, Guangdong Ocean University, Zhanjiang 524088
    2.College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642
    3.Jiangsu Sanyi Biological Engineering Co. , Ltd. , Pizhou 221000
    4.Suzhou Saifu New Drug Technology Service Co. , Ltd. , Suzhou 215021
  • Received:2025-02-25 Published:2025-10-26 Online:2025-10-28

摘要:

目的 探究虾青素(astaxanthin, AST)对黄曲霉毒素B1(aflatoxin B1, AFB1)诱导肝损伤的保护作用及分子机制。 方法 构建AFB1诱导小鼠肝实质AML21细胞和C57BL/6小鼠模型,商品化试剂盒检测AST处理后生化指标(谷草转氨酶、谷丙转氨酶和碱性磷酸酶)、氧化指标(ROS、MDA、SOD、GSH和CAT)和炎症指标(IL-1β和IL-18)的水平,蛋白质免疫印迹(western blot, WB)方法检测AST对Nrf2和焦亡信号通路的影响。 结果 体内外结果一致表明,AST可有效缓解AFB1导致的生化指标、氧化指标和炎症指标的异常。AST激活Nrf2信号通路,显著升高抗氧化蛋白NQO1、HO-1、GCLC和GCLM的水平;Nrf2抑制剂ML385处理AML21细胞后,Nrf2、NQO1和HO-1蛋白表达水平显著降低,AST和ML385共同处理后,蛋白表达水平被显著逆转。另外,AST还能抑制焦亡途径,显著降低NLRP3、ASC、Caspase-1和GSDMD蛋白表达水平。 结论 AST通过激活Nrf2信号通路抑制细胞焦亡,从而抵抗氧化应激和炎症反应,缓解AFB1诱导肝损伤。

关键词: 虾青素, 黄曲霉毒素B1, 肝损伤, 氧化应激, 炎症, 焦亡

Abstract:

Objective To investigate the protective effects and molecular mechanisms of astaxanthin (AST) on aflatoxin B1 (AFB1)-induced liver injury. Method AFB1-induced mouse hepatic parenchymal AML21 cells and C57BL/6 mouse models were constructed, and commercial kits were used to detect the levels of biochemical markers (aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase), oxidative markers (ROS, MDA, SOD, GSH, and CAT), and inflammatory markers (IL-1β and IL-18) after AST treatment. The impact of AST on the Nrf2 and pyroptosis signaling pathways was detected using the Western Blot (WB) method. Result Both in vivo and in vitro results consistently indicate that AST effectively alleviated the abnormalities in biochemical markers, oxidative markers, and inflammatory markers caused by AFB1. By activating the Nrf2 signaling pathway, AST significantly increased the levels of antioxidant proteins such as NQO1, HO-1, GCLC, and GCLM. However, the protein expression s of Nrf2, NQO1, and HO-1significantly reduced when AML21 cells were treated with the Nrf2 inhibitor ML385. But the protein expressions significantly reversed when AST and ML385 were used in combination. Additionally, AST inhibited the pyroptosis pathway, significantly decreasing the protein expressions of NLRP3, ASC, Caspase-1, and GSDMD. Conclusion AST alleviates AFB1-induced liver injury by activating the Nrf2 signaling pathway and inhibiting cell pyroptosis, thereby resisting oxidative stress and inflammatory responses.

Key words: astaxanthin, aflatoxin B1, liver injury, oxidative stress, inflammation, pyroptosis